Literature DB >> 25819801

Distribution of Candida albicans and non-albicans Candida species in oral candidiasis patients: Correlation between cell surface hydrophobicity and biofilm forming activities.

Thaniya Muadcheingka1, Pornpen Tantivitayakul2.   

Abstract

OBJECTIVES: The purposes of this investigation were to study the prevalence of Candida albicans and non-albicans Candida (NAC) species from oral candidiasis patients and evaluate the cell surface hydrophobicity (CSH) and biofilm forming capacity of the clinical isolates Candida species from oral cavity.
DESIGN: This study identified a total of 250 Candida strains isolated from 207 oral candidiasis patients with PCR-RFLP technique. CSH value, total biomass of biofilm and biofilm forming ability of 117 oral Candida isolates were evaluated.
RESULTS: C. albicans (61.6%) was still the predominant species in oral candidiasis patients with and without denture wearer, respectively, followed by C. glabrata (15.2%), C. tropicalis (10.4%), C. parapsilosis (3.2%), C. kefyr (3.6%), C. dubliniensis (2%), C. lusitaniae (2%), C. krusei (1.6%), and C. guilliermondii (0.4%). The proportion of mixed colonization with more than one Candida species was 18% from total cases. The relative CSH value and biofilm biomass of NAC species were greater than C. albicans (p<0.001). Ninety-two percent of oral isolates NAC species had biofilm forming ability, whereas 78% of C. albicans were biofilm formers. Furthermore, the significant difference of relative CSH values between biofilm formers and non-biofilm formers was observed in the NAC species (p<0.005), whereas the difference was not statistically significant in C. albicans.
CONCLUSION: The frequency of the NAC species colonization in oral cavity was gradually increasing. The possible contributing factors might be high cell surface hydrophobicity and biofilm forming ability. The relative CSH value could be a putative factor for determining biofilm formation ability of the non-albicans Candida species.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biofilm formation; Candida albicans; Cell surface hydrophobicity; Non-albicans Candida species

Mesh:

Year:  2015        PMID: 25819801     DOI: 10.1016/j.archoralbio.2015.03.002

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  21 in total

Review 1.  Ecological Therapeutic Opportunities for Oral Diseases.

Authors:  Anilei Hoare; Philip D Marsh; Patricia I Diaz
Journal:  Microbiol Spectr       Date:  2017-08

Review 2.  Innate Immunity and Saliva in Candida albicans-mediated Oral Diseases.

Authors:  O Salvatori; S Puri; S Tati; M Edgerton
Journal:  J Dent Res       Date:  2016-01-08       Impact factor: 6.116

3.  Therapeutic implications of candida phenotypes, virulence factors and antifungal sensitivity in Oral leukoplakia.

Authors:  Shalini R Gupta; Immaculata Xess; Gagandeep Singh; Alpana Sharma; Nidhi Gupta; Kalaivani Mani; Sheetal Sharma
Journal:  J Oral Biol Craniofac Res       Date:  2021-03-19

4.  From the first touch to biofilm establishment by the human pathogen Candida glabrata: a genome-wide to nanoscale view.

Authors:  Mafalda Cavalheiro; Diana Pereira; Cécile Formosa-Dague; Carolina Leitão; Pedro Pais; Easter Ndlovu; Romeu Viana; Andreia I Pimenta; Rui Santos; Azusa Takahashi-Nakaguchi; Michiyo Okamoto; Mihaela Ola; Hiroji Chibana; Arsénio M Fialho; Geraldine Butler; Etienne Dague; Miguel C Teixeira
Journal:  Commun Biol       Date:  2021-07-20

Review 5.  An Update on Candida tropicalis Based on Basic and Clinical Approaches.

Authors:  Diana L Zuza-Alves; Walicyranison P Silva-Rocha; Guilherme M Chaves
Journal:  Front Microbiol       Date:  2017-10-13       Impact factor: 5.640

Review 6.  Biomaterials for the Prevention of Oral Candidiasis Development.

Authors:  Dan Cristian Gheorghe; Adelina-Gabriela Niculescu; Alexandra Cătălina Bîrcă; Alexandru Mihai Grumezescu
Journal:  Pharmaceutics       Date:  2021-05-27       Impact factor: 6.321

7.  The Candida species that are important for the development of atrophic glossitis in xerostomia patients.

Authors:  Sachika Nakamura; Mariko R Okamoto; Ken Yamamoto; Akihisa Tsurumoto; Yoko Yoshino; Hiroshi Iwabuchi; Ichiro Saito; Nobuko Maeda; Yoichi Nakagawa
Journal:  BMC Oral Health       Date:  2017-12-16       Impact factor: 2.757

8.  A Linear 19-Mer Plant Defensin-Derived Peptide Acts Synergistically with Caspofungin against Candida albicans Biofilms.

Authors:  Tanne L Cools; Caroline Struyfs; Jan W Drijfhout; Soňa Kucharíková; Celia Lobo Romero; Patrick Van Dijck; Marcelo H S Ramada; Carlos Bloch; Bruno P A Cammue; Karin Thevissen
Journal:  Front Microbiol       Date:  2017-10-20       Impact factor: 5.640

9.  Oral candidiasis: A retrospective study of 276 Brazilian patients.

Authors:  Henrique Cortes Meira; Bruna Mascarenhas De Oliveira; Igor Figueiredo Pereira; Marcelo Drumond Naves; Ricardo Alves Mesquita; Vagner Rodrigues Santos
Journal:  J Oral Maxillofac Pathol       Date:  2017 Sep-Dec

Review 10.  Gaining Insights from Candida Biofilm Heterogeneity: One Size Does Not Fit All.

Authors:  Ryan Kean; Christopher Delaney; Ranjith Rajendran; Leighann Sherry; Rebecca Metcalfe; Rachael Thomas; William McLean; Craig Williams; Gordon Ramage
Journal:  J Fungi (Basel)       Date:  2018-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.